ESAB Corp false 0001877322 0001877322 2022-06-28 2022-06-28

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 28, 2022

 

 

ESAB Corporation

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   001-41297   87-0923837
(State or other jurisdiction
or incorporations)
  (Commission
File Number)
  (I.R.S. Employer
Identification Number)

909 Rose Avenue, 8th Floor

North Bethesda, MD 20852

(Address of Principal Executive Offices) (Zip Code)

(301) 323-9099

(Registrant’s telephone number, including area code)

Not applicable

(Former name or former address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

 

Trading
Symbol(s)

 

Name of each exchange on
which registered

Common Stock, par value $0.001 per share   ESAB   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR 230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR 240.12b-2).

Emerging growth company  

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  ☐

 

 

 


Item 1.01

Entry into a Material Definitive Agreement.

On June 28, 2022, ESAB Corporation (the “Company”) entered into Amendment No. 2 (the “Amendment”) to the credit agreement, dated as of April 4, 2022, as amended June 17, 2022, by and among the Company, as the lead borrower, the other loan parties from time to time party thereto, including certain subsidiaries of the Company identified therein, as guarantors, each of the lenders from time to time party thereto, Bank of America, N.A., as administrative agent, and the co-syndication agents, joint bookrunners and joint lead arrangers named therein (the “Credit Agreement”).

The Amendment, among other changes, provides for a senior term loan A facility in an initial aggregate principal amount of $600 million (the “New Term Loan”) to replace the Company’s existing $600 million 364-day senior term loan facility under the Credit Agreement (the “364-Day Facility”). The New Term Loan matures April 3, 2025. Proceeds from the New Term Loan were used to refinance the 364-Day Facility and to pay associated fees and expenses. The Company’s total borrowing capacity under the Credit Agreement remains unchanged.

The foregoing description of the Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Amendment, which is attached hereto as Exhibit 10.1 and is incorporated herein by reference.

 

Item 9.01

Financial Statements and Exhibits

(d) Exhibits

 

Exhibit
No.

  

Description of Exhibit

10.1    Amendment No. 2 to Credit Agreement dated as of June 28, 2022.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

 

2


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Date: June 28, 2022

 

ESAB CORPORATION
By:  

/s/ Kevin Johnson

Name:   Kevin Johnson
Title:   Chief Financial Officer